Compounding Pharmacies: Judge Erred In Allowing Drug’s Removal From Shortage List
NEW ORLEANS — Upholding a Texas federal judge’s “wayward view” in granting summary judgment to the U.S. Food and Drug Administration and Eli Lilly and Co. in a dispute over whether...To view the full article, register now.
Already a subscriber? Click here to view full article